ROYAL BANK OF CANADA - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$48,000
+108.7%
1,087
+123.2%
0.00%
Q2 2023$23,000
-37.8%
487
-48.4%
0.00%
Q1 2023$37,000
-5.1%
943
-32.7%
0.00%
Q4 2022$39,000
+225.0%
1,402
+260.4%
0.00%
Q3 2022$12,000
+20.0%
389
+22.3%
0.00%
Q2 2022$10,000
-65.5%
318
-51.5%
0.00%
Q1 2022$29,000
-65.5%
655
-63.7%
0.00%
Q4 2021$84,000
+265.2%
1,805
+175.6%
0.00%
Q3 2021$23,000
+64.3%
655
+37.6%
0.00%
Q2 2021$14,0000.0%476
-13.0%
0.00%
Q1 2021$14,000
+55.6%
547
+47.0%
0.00%
Q4 2020$9,000
+800.0%
372
+1140.0%
0.00%
Q3 2020$1,0000.0%300.0%0.00%
Q2 2020$1,000
-66.7%
30
-77.3%
0.00%
Q1 2020$3,0000.0%1320.0%0.00%
Q4 2019$3,000
+200.0%
132
+388.9%
0.00%
Q3 2019$1,0000.0%270.0%0.00%
Q2 2019$1,000
-80.0%
27
-84.7%
0.00%
Q1 2019$5,000
-85.3%
177
-87.0%
0.00%
Q4 2018$34,000
-33.3%
1,3660.0%0.00%
Q3 2018$51,000
+104.0%
1,366
+12.3%
0.00%
Q2 2018$25,000
+8.7%
1,216
-25.0%
0.00%
Q1 2018$23,000
-8.0%
1,6220.0%0.00%
Q4 2017$25,000
+56.2%
1,622
-0.4%
0.00%
Q3 2017$16,000
-11.1%
1,628
-23.4%
0.00%
Q2 2017$18,000
+1700.0%
2,125
+1886.0%
0.00%
Q1 2017$1,000
-97.7%
107
-97.2%
0.00%
Q4 2016$43,000
+13.2%
3,867
+72.0%
0.00%
Q3 2016$38,000
+90.0%
2,248
+144.6%
0.00%
Q2 2016$20,000
+25.0%
919
+10.3%
0.00%
Q1 2016$16,000
+300.0%
833
+427.2%
0.00%
Q3 2015$4,0000.0%158
-14.6%
0.00%
Q2 2015$4,0001850.00%
Other shareholders
IRADIMED CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders